Loading...

Il Pre Meeting Course è ormai un appuntamento tradizionale dell’Associazione che precede le due giornate di Riunione Annuale; è un evento aperto a Soci e non Soci, che focalizza l’attenzione su uno specifico ed attuale tema epatologico.

PRE MEETING 2025
“Artificial Intelligence in Hepatology: From Theory to Clinical Practice``

(Roma, 26 Marzo 2025)
CENTRO CONGRESSI “AUDITORIUM DELLA TECNICA”
Viale Umberto Tupini, 65

PRE MEETING 2024
“A multidisciplinary approach to the management of liver disease“

(Roma, 13 Marzo 2024)
CENTRO CONGRESSI “AUDITORIUM DELLA TECNICA”
Viale Umberto Tupini, 65

PRE MEETING 2023
“Surviving tough liver referrals: between evidence and real world practice“

(Roma, 15 Marzo 2023)
CENTRO CONGRESSI “AUDITORIUM DELLA TECNICA”
Viale Umberto Tupini, 65

PRE MEETING 2022
“Management of Hepatocellular Carcinoma in 2022“

(Roma, 23 Marzo 2022)
CENTRO CONGRESSI “AUDITORIUM DELLA TECNICA”
Viale Umberto Tupini, 65

PRE MEETING 2021
“Liver Transplantation 2021: a new era``

(Virtual Meeting, 22 Febbraio 2021)

PRE MEETING 2020 - ANNULLATO CAUSA EMERGENZA SANITARIA

“Liver Transplantation 2020: a new era”

(Roma, 26 Febbraio 2020)

PRE MEETING 2019

“Lifestyle and the Liver: the New Frontier for Hepatologists”

(Roma, 20 Febbraio 2019)

PRE MEETING 2018

“Invasive procedures in Hepatology”

PRE MEETING 2017

“Vascular diseases of the liver”

PRE MEETING 2016

“Update on the Management of Acute Liver Failure”

PRE MEETING 2015

“Future Scenarios in Hepatology”

PRE MEETING 2014

“Indications to liver transplantation and management of patients in the waiting list”

PRE MEETING 2013

“Treatment of hepatocellular carcinoma”

PRE MEETING 2012

“HCV treatment: the new scenario in the era of Direct-acting Antiviral Agents (DAAs)”

PRE MEETING 2011

Difficult Clinical Issues in Hepatology”

PRE MEETING 2010

Liver Diseases, Life Style and Behaviour ”

PRE MEETING 2009

Genetic in  the diagnosis and treatment of patients with chronic liver injury ”

PRE MEETING 2008

Management of HBV-related liver disease”

PRE MEETING 2007

Management of HCV-related disease”